XTL Biopharmaceuticals Ltd (XTLB) stock
XTLBNasdaqPharmaceutical Preparations
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Jun 30, 2026Score 0/30
$1.37−0.11 (-7.43%)
Close on Nov 20, 2026Market cap $12.96MP/E –Yield –
XTL Biopharmaceuticals net income
Net income is the profit left for shareholders after every expense, interest and tax.
For fiscal 2015 it was $2.00K.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | $2.00K | – |
See a number that looks wrong?